Qfix partners with Apollo Hospitals in India for proton cancer center

By News Release


Apollo Hospitals and Qfix announce a partnership that will allow Indian proton therapy patients to benefit from patient-positioning and fixation technology. Qfix is providing a full suite of equipment to the new Apollo Proton Cancer Centre (APCC) in Chennai. APCC will have a 3-room proton therapy solution with comprehensive cancer center.

John Chandy, Vice President, Proton Therapy & Oncology, Apollo Proton Cancer Center said, “Proton therapy requires efficient and accurate treatments for patient well-being and favorable long-term outcomes. Qfix was a natural choice for us and this marks the start of a long-term collaboration with Qfix to serve patients in India. We look forward to the commissioning of the Apollo Proton Cancer Center in early November 2018 (first proton patient treatments), with patients from all over the world benefiting from the advanced combination of protons and state-of-the-art patient positioning.”

Stuart Baldwin, Director of International Business Development at Qfix, commented, “There are many Indian patients who can benefit from advanced therapies and techniques for cancer care such as proton therapy with high-quality immobilization. We are delighted that such a prestigious group as Apollo have chosen to partner with us for the long-term. Their decision reinforces both the market leadership of Qfix and the importance of high-quality patient positioning to advancing cancer therapy for patients worldwide.”

Back To Top

Qfix partners with Apollo Hospitals in India for proton cancer center .  Appl Rad Oncol. 

By News Release| October 08, 2018
Categories:  Section|Technologies

About the Author

News Release

News Release


Copyright © Anderson Publishing, Ltd

    Agility CMS